-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The competitive landscape of blood products is changing
Open the prelude to the collection of biosimilar drugs
Such a situation is a big challenge for Roche: In 2021, Roche's pharmaceutical business in China will generate US$3.
6 billion (3.
276 billion Swiss francs), accounting for 7.
3% of Roche's global pharmaceutical business revenue
Some groups are in fierce competition
According to the data from Minet.
com, although the overall sales of cephalosporin products have declined due to the impact of policies in recent years, injection products can exert their efficacy more quickly and have better curative effect because they can be injected through intravenous infusion or intramuscular injection.
, its market leadership remains unshakable, with its market share rising to 88.
28% in 2020